Overview of the Global Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses

The global prophylactic medicaments containing insulin market was estimated at $X.4B in 2022, picking up by X% against the previous year. Overall, the total consumption indicated a prominent increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by X% against 2020 indices. Global consumption peaked at $X.5B in 2020; however, from 2021 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

In value terms, prophylactic medicaments containing insulin production reached $X.2B in 2022 estimated in export price. In general, the total production indicated a strong increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by X% against 2020 indices. The most prominent rate of growth was recorded in 2013 with an increase of X%. Global production peaked at $X.9B in 2020; however, from 2021 to 2022, production failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports

In 2022, overseas shipments of medicaments containing insulin but not antibiotics in measured doses increased by X% to X tons, rising for the second consecutive year after two years of decline. The total export volume increased at an average annual rate of X% from 2012 to 2022; the trend pattern remained consistent, with only minor fluctuations being recorded throughout the analyzed period. The growth pace was the most rapid in 2013 when exports increased by X%. Over the period under review, the global exports attained the maximum in 2022 and are expected to retain growth in years to come.

In value terms, prophylactic medicaments containing insulin exports declined to $X in 2022. Over the period under review, exports recorded a relatively flat trend pattern. The pace of growth was the most pronounced in 2013 when exports increased by X%. Over the period under review, the global exports attained the peak figure at $X in 2014; however, from 2015 to 2022, the exports remained at a lower figure.

Exports by Country

In 2022, France (X tons) represented the major exporter of medicaments containing insulin but not antibiotics in measured doses, mixing up X% of total exports. It was distantly followed by the United States (X tons), Italy (X tons), India (X tons), Germany (X tons), China (X tons) and Brazil (X tons), together generating a X% share of total exports.

Exports from France increased at an average annual rate of X% from 2012 to 2022. At the same time, China (X%), Italy (X%) and the United States (X%) displayed positive paces of growth. Moreover, China emerged as the fastest-growing exporter exported in the world, with a CAGR of X% from 2012-2022. Germany experienced a relatively flat trend pattern. By contrast, India (X%) and Brazil (X%) illustrated a downward trend over the same period. While the share of France (X p.p.), China (X p.p.) and Italy (X p.p.) increased significantly in terms of the global exports from 2012-2022, the share of Germany (X p.p.), Brazil (X p.p.) and India (X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest prophylactic medicaments containing insulin supplying countries worldwide were Germany ($X), France ($X) and China ($X), with a combined X% share of global exports.

China, with a CAGR of X%, saw the highest rates of growth with regard to the value of exports, among the main exporting countries over the period under review, while shipments for the other global leaders experienced more modest paces of growth.

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2022, declining by X% against the previous year. Overall, the export price continues to indicate a perceptible contraction. The growth pace was the most rapid in 2014 when the average export price increased by X%. As a result, the export price attained the peak level of $X per ton. From 2015 to 2022, the average export prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Germany ($X,541 per ton), while Brazil ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by India (X%), while the other global leaders experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports

In 2022, overseas purchases of medicaments containing insulin but not antibiotics in measured doses decreased by X% to X tons, falling for the second consecutive year after three years of growth. The total import volume increased at an average annual rate of X% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth appeared the most rapid in 2013 with an increase of X%. Over the period under review, global imports attained the peak figure at X tons in 2020; however, from 2021 to 2022, imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports declined remarkably to $X in 2022. Over the period under review, imports recorded a slight descent. The growth pace was the most rapid in 2013 with an increase of X% against the previous year. Global imports peaked at $X in 2014; however, from 2015 to 2022, imports failed to regain momentum.

Imports by Country

In 2022, the United States (X tons) and France (X tons) were the main importers of medicaments containing insulin but not antibiotics in measured dosesacross the globe, together generating X% of total imports. Germany (X tons) took a X% share (based on physical terms) of total imports, which put it in second place, followed by Turkey (X%) and Canada (X%). Algeria (X tons), Japan (X tons), Spain (X tons), Hungary (X tons), Italy (X tons), Iran (X tons), Colombia (X tons) and China (X tons) followed a long way behind the leaders.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the leading importing countries, was attained by Iran (with a CAGR of X%), while imports for the other global leaders experienced more modest paces of growth.

In value terms, the largest prophylactic medicaments containing insulin importing markets worldwide were the United States ($X), France ($X) and Germany ($X), together accounting for X% of global imports. Canada, Japan, China, Algeria, Iran, Hungary, Turkey, Italy, Spain and Colombia lagged somewhat behind, together accounting for a further X%.

Iran, with a CAGR of X%, recorded the highest growth rate of the value of imports, among the main importing countries over the period under review, while purchases for the other global leaders experienced more modest paces of growth.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, falling by X% against the previous year. Overall, the import price saw a pronounced reduction. The most prominent rate of growth was recorded in 2013 an increase of X% against the previous year. Global import price peaked at $X per ton in 2014; however, from 2015 to 2022, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was China ($X per ton), while Colombia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by France (X%), while the other global leaders experienced a decline in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :